Dr Charmaine Lye1,2,3, Ms Sally Munoch1,2, Ms Teresa Lewis1,2, Dr Lachlan Wasson1, Dr Randy Tjang1, Dr Samantha Quoy1,2,3, Dr Emily Ong1, Dr Sarah Browning1,2,3
1Hunter New England Local Health District, Newcastle, Australia, 2Hunter Medical Research Institute, Infection Research Program, Newcastle, Australia, 3University of Newcastle, School of Medicine and Public Health, Newcastle, Australia
Biography:
Dr Sarah Browning is the Clinical Director of the Hunter New England Local Health District Infection Prevention Service. She is a Conjoint Senior Lecturer at the University of Newcastle. Dr Browning is currently completing a PhD at the University of Newcastle which focuses on the acquisition of MROs.
Abstract:
Introduction
Automated Flexible Endoscope Reprocessors (AFERs) are critical to reducing the risk of cross-contamination and infection in endoscopy by ensuring effective cleaning and disinfection of endoscopes. In Australia, compliance with Action 3.17 of the National Safety and Quality Health Service (NSQHS) Standards mandates that endoscope reprocessing aligns with both national and international guidelines, as well as manufacturers' instructions. Despite this, real-world implementation is hindered by inconsistent guideline interpretation, variability in testing practices, and limited direction for managing abnormal results—factors that may compromise infection prevention and patient safety.
Methods
Our research team conducted an extensive literature review on endoscope reprocessing and AFER management. We used this information to develop SAFER (the Survey of Automated Flexible Endoscope Reprocessing) which aims to identify current practices and challenges relating to AFER final rinse water testing. Healthcare professionals involved in endoscope reprocessing across Australia and New Zealand have been invited to participate in this study by completing an online survey (30 minutes)
Results
SAFER will close recruitment on 30 June 2025. Preliminary analysis of survey data indicates significant variability in reprocessing practices, including the interpretation and management of abnormal rinse water results.
Conclusion
It is envisaged that this study will identify gaps in standardisation, inconsistencies in risk mitigation strategies, and the potential implications for patient safety. These insights underscore the need for clearer national guidance and improved quality control measures to support safer and more consistent endoscope reprocessing.